INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Quarterly Results

Change Company Name

Mankind Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 543904	ISIN Demat INE634S01028	Book Value 375.73	NSE Symbol MANKIND	Dividend Yield (%) 0	Market Cap (₹ Cr.) 89,972.93	P/E 54	EPS 40.36	Face Value 1

Particulars (₹ Cr)	Sep 2025	Jun 2025	Mar 2025	Dec 2024

Gross Sales/Income from operations	2608.78	2541.36	2126.59	2414.41
Less: Excise duty	0.00	0.00	0.00	0.00
Net Sales/Income from operations	2,608.78	2,541.36	2,126.59	2,414.41
Other Operating Income	0.00	0.00	0.00	0.00
Total Income from operations (net)	2,608.78	2,541.36	2,126.59	2,414.41
Total Expenses	2,014.62	1,965.22	1,754.91	1,759.42
Cost of Sales	710.76	669.64	557.48	654.37
Employee Cost	600.29	584.87	536.75	530.68
Depreciation, amortization and depletion expense	99.03	96.93	105.24	91.11
Provisions & Write Offs	0.00	0.00	15.82	0.00
Administrative and Selling Expenses	0.00	0.00	0.00	0.00
Other Expenses	604.54	613.78	539.62	483.26
Pre Operation Expenses Capitalised	0.00	0.00	0.00	0.00
Profit from operations before other income, finance costs and exceptional items	594.16	576.14	371.68	654.99
Other Income	77.67	64.22	219.32	70.37
Profit from ordinary activities before finance costs and exceptional items	671.83	640.36	591.00	725.36
Finance Costs	147.20	146.70	162.25	200.27
Profit from ordinary activities after finance costs but before exceptional items	524.63	493.66	428.75	525.09
Exceptional Items	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00
Profit from ordinary activities before tax	524.63	493.66	428.75	525.09
Total Tax	65.73	80.90	46.29	113.07
Net profit from Ordinary Activities After Tax	458.90	412.76	382.46	412.02
Profit / (Loss) from Discontinued Operations	0.00	0.00	0.00	0.00
Net profit from Ordinary Activities/Discontinued Operations After Tax	458.90	412.76	382.46	412.02
Extraordinary items	0.00	0.00	0.00	0.00
Other Adjustments After Tax	0.00	0.00	0.00	0.00
Net Profit after tax for the Period	458.90	412.76	382.46	412.02
Other Comprehensive Income	15.79	1.06	-3.27	9.41
Total Comprehensive Income	474.69	413.82	379.19	421.43
Equity	41.28	41.26	41.26	40.06
Reserve & Surplus	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00
EPS:
EPS before Exceptional/Extraordinary items-Basic	11.12	10.00	9.27	10.35
EPS before Exceptional/Extraordinary items-Diluted	11.10	9.99	9.25	10.33
EPS after Exceptional/Extraordinary items-Basic	11.12	10.00	9.27	10.35
EPS after Exceptional/Extraordinary items-Diluted	11.10	9.99	9.25	10.33
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00
Dividend Per Share(Rs.)	1.00	1.00	0.00	0.00
Dividend (%)	100.00	100.00	0.00	0.00
No. of Employees	0.00	0.00	0.00	0.00
Debt Equity Ratio	0.00	0.46	0.50	0.00
Debt Service Coverage Ratio	0.00	0.76	0.12	0.00
Interest Service Coverage Ratio	0.00	3.93	2.29	0.00
Debenture Redemption Reserve (Rs cr)	0.00	0.00	0.00	0.00
Paid up Debt Capital (Rs cr)	0.00	0.00	0.00	0.00